Immunohistochemistry (IHC) has emerged as a crucial tool in the field of precision medicine, revolutionizing the way personalized therapies are developed and implemented.
By assessing protein expression patterns in patient samples, Immunohistochemistry enables researchers and clinicians to identify specific molecular targets that can guide treatment decisions. This approach allows for the selection of therapies tailored to individual patients, maximizing treatment efficacy and minimizing adverse effects.
Immunohistochemistry plays a key role in identifying predictive biomarkers, such as hormone receptors in breast cancer or PD-L1 expression in immune checkpoint inhibitors for cancer immunotherapy. The integration of IHC with precision medicine holds great promise for improving patient outcomes and transforming the way diseases are treated.
Read More- http://wordoid01.weebly.com/cmi-article/4243591
Comments
0 comment